
Existing Drug Repurposed for Rare Autism via Genetic Fingerprinting
Researchers utilised a high-throughput platform to analyse the genetic 'fingerprint' of a rare form of autism called 19q12 ASD. By screening existing drugs, they discovered that entrectinib could reverse the disease's genetic signature, leading to successful off-label treatment in a patient.
By Guin, Haditsch, Bellucci, Topka, Dyer, Del Toro, Blanco, Downs, Perfito, Mahadevan, Moxham

